Clinical trial
Use of QuantiFERON® CMV in the Therapeutic Decision in Asymptomatic CMV Infection in Solid Organ Transplant Recipients
NCT06341543 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of QuantiFERON® CMV in the Therapeutic Decision in Asymptomatic CMV Infection in Solid Organ Transplant Recipients
- Lead sponsor
- University Hospital, Grenoble
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 24, 2024
- Completion date
- October 31, 2026
- Enrollment
- 288 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cytomegalovirus infections, heart transplantation, kidney transplantation, liver transplantation, lung transplantation